Peptide Research and Healthy Aging Trending: A Wider Healthy-Aging Lens A new 2026 scientific review is bringing aesthetic, metabolic, and endocrine peptide research into one conversation. Topics such as GHK-Cu are being studied alongside broader questions about skin biology, cellular…
A concise MOTS-c research brief for women over 40 with Luvi peptide education resources and a research-reading tip.
GLP-1 wellness research for women over 40: fall-risk literature, healthy-aging context, Luvi education resources, and research-only reading tips.
A concise MOTS-c research brief for women over 40, with Luvi peptide education resources and a study-design reading tip.
Healthy Aging Research Notes This week’s wellness conversation is centered on healthy aging research, especially how metabolic pathways, peptide libraries, and skin-support research topics are being discussed in women’s wellness circles. For women over 40 in Canada, the most useful…
Subject: Retatrutide Research Update: GLP-1 Trends Retatrutide continues to stand out as one of the most closely watched metabolic research compounds in the current peptide landscape. In recent trend monitoring, retatrutide showed strong year-over-year search growth and continued week-over-week momentum,…
Are Peptides Legal Again After the 2026 FDA Ruling? If you’ve been following the peptide space, you probably saw the news: on April 15, 2026, the FDA removed 12 peptides — including BPC-157 and TB-500 — from the Category 2…
On April 15, 2026, the FDA made one of the most significant regulatory moves in the peptide space in years: they removed 12 peptides — including BPC-157, TB-500, and Semax — from the Category 2 restricted substances list. If you’ve…
A comprehensive research-based FAQ on BPC-157 side effects, covering what preclinical data shows, common questions from the research community, and important safety context.
BPC-157 oral vs injectable — which route shows better bioavailability? Learn the research differences, stability, absorption, and GI-specific effects.